| PERIOD ENDING | 31-Mar-06 | 31-Mar-05 | | Total Revenue | 1,356 | 872 | | Cost of Revenue | 208 | 174 | | | Gross Profit | 1,147 | 698 | | | Operating Expenses | | Research Development | 3,357 | 2,745 | | Selling General and Administrative | 6,134 | 5,672 | | Non Recurring | (318) |
-
| | Others | 212 | 150 | | | | Total Operating Expenses | 9,385 |
-
| | | | Operating Income or Loss | (8,238) | (7,868) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 205 | 274 | | Earnings Before Interest And Taxes | (8,033) | (7,595) | | Interest Expense | 8 | 16 | | Income Before Tax | (8,041) | (7,610) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (8,041) | (7,610) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (8,041) | (7,610) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($8,041) | ($7,610) |
|
0.20% Nasdaq 
Income Statement
